A premier contract development and manufacturing organization (CDMO), Vetter is a global leader in the fill & finish contract manufacturing of aseptically prefilled syringe systems, cartridges, and vials. We are a family-owned, independent company with facilities both in Germany and the US, as well as offices in Singapore and Japan. Our focus is on providing state-of-the-art manufacturing, from early clinical development and scale-up to commercial filling and packaging of parenteral drugs. We support you every step of the way, guiding your product through development, regulatory approval, launch, and life cycle management. Vetter offers you a foundation of experience spanning more than 35 years including dozens of product approvals for novel pharmaceutical and biotech compounds.
Growth of prefilled syringes continues to reflect the growth in biologics, complex compounds, and increasing requirements for patients and healthcare workers. Experts project that by 2024, the prefilled market will reach 6 billion units. Prefilled syringes offer innovative delivery options, help achieve market advantages at launch, and act as a valuable life cycle management strategy.
Customer award from one of the top-20 biopharmaceutical companies was granted for meeting ‘predetermined high-level demands of service’.
Susanne Resatz, President of Vetter Development Services USA, Inc. is elected to the board of directors of the German American Chamber of Commerce® of the Midwest, Inc.